Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
212.3 USD | +1.38% | +1.79% | -15.61% |
May. 08 | Morgan Stanley Cuts Price Target on Penumbra to $235 From $240, Keeps Equalweight Rating | MT |
May. 07 | Penumbra Q1 Non-GAAP EPS, Revenue Increase; Reaffirms 2024 Revenue Outlook | MT |
Business Summary
Number of employees: 4,200
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Thrombectomy
64.0
%
| - | - | 677 | 64.0 % | - |
Embolization and Access
36.0
%
| - | - | 381 | 36.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
71.5
%
| 592 | 69.8 % | 757 | 71.5 % | +27.96% |
International
28.5
%
| 255 | 30.2 % | 301 | 28.5 % | +17.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Arani Bose
FOU | Founder | 62 | 04-06-20 |
Adam Elsesser
CEO | Chief Executive Officer | 62 | 04-06-20 |
Maggie Yuen
DFI | Director of Finance/CFO | 52 | 19-12-01 |
Ben Sorci
COO | Chief Operating Officer | - | 04-12-31 |
Corey Teigen
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-13 |
Pankaj Tiwari
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
James Benenati
CTO | Chief Tech/Sci/R&D Officer | - | 20-08-31 |
Lambert Shiu
AUD | Comptroller/Controller/Auditor | 44 | 14-12-31 |
Johanna Roberts
LAW | General Counsel | 52 | 13-12-31 |
Michaella Corso
PRN | Corporate Officer/Principal | - | 15-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Wilder
BRD | Director/Board Member | 60 | 17-01-12 |
Harpreet Grewal
BRD | Director/Board Member | 57 | 15-03-31 |
Adam Elsesser
CEO | Chief Executive Officer | 62 | 04-06-20 |
Arani Bose
FOU | Founder | 62 | 04-06-20 |
Don Kassing
BRD | Director/Board Member | 82 | 08-01-31 |
Surbhi Sarna
BRD | Director/Board Member | 38 | 19-06-30 |
Bridget O'Rourke
BRD | Director/Board Member | 56 | 17-04-20 |
Janet Leeds
BRD | Director/Board Member | 62 | 19-01-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,764,917 | 37,283,221 ( 96.18 %) | 0 | 96.18 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Crossmed SpA
Crossmed SpA Medical SpecialtiesHealth Technology Crossmed SpA distributes medical supplies and equipment in Italy, San Marino, the Vatican, and Switzerland. The company was founded in 2007 and is headquartered in Grugliasco, Italy. |
Medical Specialties
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.61% | 8.23B | |
+73.46% | 12.41B | |
+3.88% | 6.46B | |
+14.69% | 5.5B | |
+42.58% | 5.1B | |
-19.05% | 4.05B | |
-32.61% | 2.54B | |
-0.74% | 1.99B | |
+10.80% | 1.99B | |
+10.31% | 1.77B |
- Stock Market
- Equities
- PEN Stock
- Company Penumbra, Inc.